insights_auto
Why is ALNOV down ၃.၃၀%?
Dive Deeperchevron_right
ALNOV:EPA
Novacyt SA
၀.၄၃ €
arrow_downward
-၃.၃၀%(-၀.၀၁၄) 1D
နို ၂၀, GMT+၁ ၁၇:၃၅:၁၀ · EUR
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for ALNOV...
Open
၀.၄၃ €
High
၀.၄၄ €
Low
၀.၄၂ €
Mkt. cap
၂.၈၈ ကုဋေ
Avg. vol.
၁.၂၈ သိန်း
Volume
၆.၄၁ သောင်း
52-wk high
၁.၀၄ €
52-wk low
၀.၂၉ €
EPS
-၀.၃၇ €
Shares outstanding
၇.၂၆ ကုဋေ
No. of employees
၂၂၈
Open
၀.၄၃ €
High
၀.၄၄ €
Low
၀.၄၂ €
Mkt. cap
၂.၈၈ ကုဋေ
Avg. vol.
၁.၂၈ သိန်း
Volume
၆.၄၁ သောင်း
52-wk high
၁.၀၄ €
52-wk low
၀.၂၉ €
EPS
-၀.၃၇ €
Shares outstanding
၇.၂၆ ကုဋေ
No. of employees
၂၂၈
News stories
From web sources and news partners
Nacionale
·
ပြီးခဲ့သည့် ၂ နာရီ
Will the S&P 500 end 2026 down for the year? It's about 65 points above zero with 27 trading days left
NPR
·
ပြီးခဲ့သည့် ၇ နာရီ
S&P 500 sinks 3.7% and the Nasdaq composite goes negative for the year
Honolulu Star-Advertiser
·
ပြီးခဲ့သည့် ၇ နာရီ
Wall Street rout pushes S&P 500, Dow into correction
FXStreet
·
ပြီးခဲ့သည့် ၈ နာရီ
Dow Jones Industrial Average drops for a fifth day as AI rout widens
Profile
Novacyt Group is an Anglo-French biotechnology group focused on clinical diagnostics, with offices in Camberley, Surrey, United Kingdom and Vélizy-Villacoublay, France. The company produces in vitro and molecular diagnostic tests, supplying assays and reagents worldwide. Its business units include Primerdesign, Microgen Bioproducts and Lab21 Healthcare.
In January 2020 the company announced that its molecular diagnostics division, Primerdesign, had launched a molecular test for the 2019 strain of SARSr-CoV. The test was approved as eligible for procurement under the World Health Organization's Emergency Use Listing process in April 2020, meaning that the test could be supplied by the United Nations and other procurement agencies supporting the COVID-19 response. In the same month Novacyt announced a collaboration with AstraZeneca, GlaxoSmithKline and the University of Cambridge to support the UK in its COVID-19 national screening programme at a new testing laboratory at the university's Anne McLaren laboratory. Wikipedia
About Novacyt SA
CEODavid Allmond
Employees၂၂၈
Founded၂၀၀၆ ဇူ ၃
Headquarters-
SectorHealth Care
Industry-
Websitenovacyt.com